Tsvetelina Hoang

Tsvetelina Hoang

Plus aucun poste en cours
53 ans
Health Technology
Consumer Services
Commercial Services

Profil

Tsvetelina Pencheva Hoang formerly worked at Bellicum Pharmaceuticals, Inc., as Director-Translational Research from 2015 to 2018, The Phi Beta Kappa Society, as Member, and Marker Therapeutics, Inc., as Vice President-Research & Development from 2018 to 2024.
Dr. Hoang received her doctorate degree from The Johns Hopkins University and undergraduate degree and graduate degree from Yale University.

Anciens postes connus de Tsvetelina Hoang

SociétésPosteFin
MARKER THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D 01/08/2024
BELLICUM PHARMACEUTICALS, INC. Corporate Officer/Principal 01/07/2018
Corporate Officer/Principal -
Voir l'expérience en détail de Tsvetelina Hoang

Formation de Tsvetelina Hoang

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

17

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées5

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

  1. Bourse
  2. Insiders
  3. Tsvetelina Hoang